Skip to content

Bioalmanac

Deadpool

Deadpool stack · Deadpool blend

Preclinical

Status reviewed 25 Aug 2026

Prohibited in sport

Wolverine with KPV added and the ratio tilted toward TB-500: 10 mg TB-500 with 5 mg each of BPC-157 and KPV. Documented at a single vendor.

Storage

Freeze-dried powder
Refrigerated at 2–8 °C, protected from light.
After mixing
Refrigerated at 2–8 °C and used within about 30 days. A blend cannot be split. A contaminated vial takes every component with it.
Long-term, frozen
Unopened powder is stable at −20 °C or colder.

Reconstitution — 20 mg vial, 500 mcg dose

On a 1 mL U-100 syringe. Check every figure against your own vial before drawing.

Water addedConcentrationVolume to drawUnitsDoses per vial
1 mL20 mg/mL0.025 mL2.5 units40
2 mL10 mg/mL0.05 mL5 units40
3 mL6.667 mg/mL0.075 mL7.5 units40
5 mL4 mg/mL0.125 mL12.5 units40

Dose ranges reported in sources

Descriptions of what sources report, not recommendations.

GoalRangeFrequencySource
Commonly described community protocol500–1000 mcgDaily, in courses of 4 to 8 weeksCommunity practice

When to stop

  • Any allergic response: rash, hives, facial swelling or difficulty breathing. Seek urgent care.
  • An injection site that becomes hot, spreading or produces pus.
  • Any new or changing lump. Two components are associated with proliferation in animal models.

Not approved anywhere as a mixture or as any of its parts. Sold as a research chemical, and documented at fewer vendors than GLOW, KLOW or Wolverine.

Arithmetic on values you enter. Not medical advice. Not reviewed by a clinician. · bioalmanac.com/peptides/deadpool

Use your browser’s print dialog and choose “Save as PDF”. This block is hidden when printed.